Related by context. All words. (Click for frequent words.) 80 cell carcinoma RCC 76 dasatinib Sprycel ® 74 erlotinib Tarceva ® 74 metastatic colorectal 74 gastrointestinal stromal tumor GIST 74 imatinib Gleevec ® 74 refractory chronic lymphocytic 73 receptor tyrosine kinase inhibitor 73 evaluating tivozanib 73 IMiDs ® compound 73 systemic anaplastic large 73 unresectable locally advanced 73 EGFr expressing metastatic colorectal 72 dasatinib Sprycel 72 tumors GIST 72 BCG refractory carcinoma 72 sunitinib Sutent ® 72 MAGE A3 ASCI 72 myelodysplastic myeloproliferative diseases 72 vinca alkaloid 72 recurrent glioblastoma multiforme 72 metastatic GIST 72 nilotinib Tasigna ® 71 CYT# potent vascular disrupting 71 sorafenib tablets 71 hypereosinophilic syndrome 71 stage IIIb IV 71 essential thrombocythemia ET 71 Peginterferon alfa 2b 71 LHRH receptor positive 71 Cutaneous T 71 interferon beta 1a infertility 71 IMiDs ® 71 Aflibercept 71 recurrent NSCLC 71 cutaneous T 71 candidates Azedra TM 71 R sorafenib tablets 71 5 FU leucovorin 71 modified glutathione analog 71 oropharyngeal candidiasis OPC 71 familial amyloidotic polyneuropathy FAP 71 cetuximab Erbitux R 71 IMiDs R 71 evaluating picoplatin 70 accumulate preferentially 70 FUSILEV enhances 70 Combination REOLYSIN R 70 imatinib mesylate 70 castrate resistant prostate cancer 70 antiangiogenesis therapies 70 acyclovir Lauriad R 70 Wafer polifeprosan 70 intravesical infusion therapy 70 VEGFR2 inhibitor 70 relapsed leukemia 70 HGS ETR1 mapatumumab 70 oral dual endothelin 70 Vidaza ® 70 kidney urologic 70 cell lymphoma CTCL 70 Hsp# Inhibitor 70 Amgen Neulasta R 70 PDX pralatrexate 70 irinotecan doxorubicin oxaliplatin paclitaxel 70 PNP inhibitor 70 ® lenalidomide 70 refractory NSCLC 70 novel VDA molecule 70 metastatic castration resistant 70 investigational oral inhibitor 70 sarcoma melanoma 70 Relapsed Refractory 70 R Saizen R 69 Phase #b/#a clinical 69 docetaxel Taxotere ® 69 Xeloda ® 69 vinca alkaloids 69 alkylating agent 69 SPRYCEL ® 69 5 fluorouracil leucovorin 69 Neulasta R 69 GW# [003] 69 bladder ovarian 69 triggers apoptosis programmed 69 metastatic pancreatic 69 Romidepsin 69 M2 subunit 69 Panzem NCD 69 Diffuse Large B 69 PEGylated Fab fragment 69 vapreotide acetate 69 EGFR expressing metastatic colorectal 69 R lenalidomide 69 Kit CD# positive 69 alvespimycin 69 IgG1 monoclonal antibody 69 relapsing remitting MS RRMS 69 telomerase therapeutic 69 rHuPH# recombinant human 69 Darinaparsin 69 Tarceva TM 69 chronic eosinophilic leukemia 69 plus dacarbazine 69 stage IIIB 69 Epratuzumab 69 refractory cutaneous T 69 temsirolimus Torisel 69 selective kinase inhibitor 69 metastatic neuroendocrine tumors 69 Albuferon TM 68 alfa 2a 68 Initiates Enrollment 68 relapsed MM 68 imatinib resistant 68 nucleoside analog 68 LymphoStat B belimumab 68 ribonucleotide reductase clinically validated 68 lexidronam injection 68 Annamycin 68 EGFR expressing mCRC 68 Zorbtive TM 68 Patients Treated With 68 Naive Patients 68 oncolytic virus therapies 68 Fludara ® 68 PI3K/Akt pathway inhibitor 68 ® bortezomib 68 virus HCV protease inhibitor 68 GRNOPC1 contains 68 toenail onychomycosis 68 bevacizumab Avastin R 68 lung pancreatic 68 paclitaxel cisplatin 68 anthracycline taxane 68 irinotecan containing 68 non squamous 68 plus prednisone prednisolone 68 non splenectomized 68 Voreloxin 68 Pharmacokinetics PK 68 Luteinizing Hormone Releasing Hormone 68 chemotherapy cisplatin 68 papillary renal cell carcinoma 68 FOLFOX6 chemotherapy regimen 68 AAG geldanamycin analog 68 advanced unresectable 68 thalidomide Thalomid 68 fallopian tube carcinoma 68 Soft Tissue Sarcoma 68 superficial basal cell carcinoma 68 Amgen Neulasta ® 68 humanised monoclonal antibody 68 Ribavirin causes 68 Dementia Related Psychosis 68 rheumatoid arthritis psoriatic arthritis 68 Solazed TM 68 situ CIS 68 Syndrome LEMS 68 lenalidomide Revlimid R 68 hormone refractory metastatic prostate 68 bevacizumab Avastin ® 68 COPEGUS R 68 paclitaxel Taxol R 68 trastuzumab Herceptin R 68 vinorelbine tartrate 68 cyclophosphamide methotrexate 68 demonstrated antitumor activity 68 oral Janus kinase 68 delivers fluocinolone acetonide FA 68 Pazopanib 68 Complicated Skin 68 sapacitabine CYC# 68 recurrent metastatic ovarian cancer 68 Vidaza R 68 INSPIRE Trial Phase III 68 metastatic malignant 68 YONDELIS 68 multi kinase inhibitor 68 methylnaltrexone bromide 68 TNF Tumor Necrosis Factor 68 sorafenib Nexavar 68 gefitinib Iressa 68 unresectable tumors 67 CTAP# 67 Omacetaxine 67 relapsed refractory multiple myeloma 67 Pruvel TM 67 Vidaza azacitidine 67 pan HDAC inhibitor 67 Immunotherapeutic 67 oral prodrug 67 nucleotide analogue 67 mitogen activated ERK kinase 67 Receives Orphan Drug Designation 67 Elotuzumab 67 Ph + acute lymphoblastic 67 included exfoliative dermatitis 67 Tibotec Therapeutics division 67 resistant hormone refractory 67 generation purine nucleoside 67 cutaneous T cell 67 ® adefovir dipivoxil 67 antibody MAb 67 Myelofibrosis 67 docetaxel Taxotere R 67 Alfacell proprietary ribonuclease 67 metastatic castrate resistant 67 tumor activated prodrug 67 Irinotecan 67 non nucleoside inhibitor 67 Initiates Clinical Trial 67 Ovitrelle R Serostim 67 Platinol ® cisplatin 67 oral ghrelin agonist 67 cisplatin gemcitabine 67 Talabostat 67 pralatrexate injection folate analogue 67 Initiates Phase II 67 peripherally acting 67 Provectus Pharmaceuticals specializes 67 Granted Orphan Drug 67 NEBIDO VANTAS SUPPRELIN LA 67 metastatic renal cell carcinoma 67 indinavir Crixivan 67 Atypical Hemolytic Uremic Syndrome 67 brand ciclesonide HFA 67 HER2 positive metastatic breast 67 arthritis PsA 67 hypoxia activated prodrug 67 FOLOTYN ® 67 chronic myeloid 67 metastatic HER2 negative 67 Amrubicin 67 chemosensitizer 67 topical gel formulation 67 histone deacetylase HDAC inhibitor 67 Vitrasert R 67 mapatumumab 67 Mg Usa 67 registrational Phase 67 lymphoma CTCL 67 relapsed multiple myeloma 67 biliary tract cancer 67 evaluating REVLIMID 67 taxane resistant 67 PEGylated docetaxel 67 CTAP# Capsules 67 R metformin Concor 67 unique alkylating agent 67 MCSP respectively 67 Refractory Hodgkin Lymphoma 67 targeted antifolate 67 ritonavir boosted 67 herpetic keratitis 67 hyperplasia BPH 67 metastatic ocular 67 potent triglyceride lowering 67 developing Bicifadine serotonin 67 orally administered inhibitor 67 GVAX ® 67 Gleevec resistant 67 atypical Hemolytic Uremic Syndrome 67 XL# XL# 67 metastatic renal 67 ATC ovarian cancer 67 small molecule Hedgehog 67 ergot derivatives 67 PRN FDA Approves 67 monoclonal antibody conjugated 67 Trial Evaluating 67 particularly SANCTURA XR 67 MKC# MT 67 ceftazidime 67 metastatic gastric 67 Friedreich Ataxia FRDA 67 humanized interleukin 6 67 Crofelemer budesonide foam 67 orally inhaled migraine 67 TO AVOID PREGNANCY WHILE 67 5 FU capecitabine 67 cladribine Cladribine Tablets 67 Refractory Peripheral T 67 mTOR mammalian target 67 squamous non 67 ATRA IV 67 Adjuvant Treatment 67 Vicinium TM 67 trabectedin 67 CYP#A# substrate 67 ThermoDox R 66 AVASTIN 66 Mg Uk 66 Bosutinib 66 Clolar ® 66 multiple myeloma MM 66 vitreoretinal disorders 66 highly selective inhibitor 66 targeted radiotherapeutic 66 infectious diseases autoimmune diseases 66 formerly LymphoStat B 66 MTP inhibitor 66 Cloretazine 66 Enzastaurin 66 Personalized Immunotherapy 66 ovarian esophageal 66 Oral Fingolimod 66 Silodosin 66 novel tubulin binding 66 AA Amyloidosis 66 Iluvien ® 66 Sudhir Agrawal D.Phil 66 Daclizumab 66 indolent follicular non 66 Advanced Renal Cell 66 denileukin diftitox 66 mertansine 66 diarrhea predominant irritable 66 Anti VEGF 66 evaluating satraplatin 66 Known hypersensitivity 66 gastrointestinal stromal tumors GIST 66 constipation OIC 66 sodium glucose cotransporter 66 Azacitidine 66 recurrent epithelial ovarian 66 Bayer HealthCare Onyx Pharmaceuticals 66 dexamethasone Decadron 66 Nexavar sorafenib 66 complement inhibitor eculizumab 66 Blinatumomab 66 humanized therapeutic 66 #I TM# 66 Budesonide foam crofelemer 66 myelofibrosis polycythemia vera 66 nilotinib Tasigna 66 interferon gamma 1b 66 alefacept 66 microtubule inhibitor 66 refractory chronic myeloid 66 liver colon rectal 66 Investigational Treatment 66 Deforolimus 66 pan histone deacetylase 66 liposomal formulation 66 adalimumab Humira 66 gastrointestinal stromal tumors 66 Recombinant interferon alpha 66 non myeloid malignancies 66 AKT inhibitor 66 leukemia CLL 66 trastuzumab DM1 T DM1 66 AN# topical anti 66 nonmetastatic 66 gastrointestinal stromal 66 induced mucositis 66 Lubiprostone 66 itraconazole Sporanox 66 Interferon alfa 2b 66 inflammatory PDE 66 sunitinib malate 66 oral ferric iron 66 proteasome inhibitor 66 Hodgkin lymphoma HL 66 Cancer AACR NCI 66 topically applied SEPA 66 non resectable 66 apomorphine hydrochloride 66 subependymal giant cell 66 PEGylated anti 66 novel emulsion formulation 66 Antitumor Activity 66 doxorubicin Adriamycin 66 MetroGel 66 induced macular edema 66 inhalation powder 66 unresectable recurrent 66 Achieves Primary Endpoint 66 Brentuximab Vedotin SGN 66 endocrine therapies 66 unresectable Stage III 66 acetonide FA 66 commercializing oxidized glutathione 66 CD4 monoclonal antibody 66 superficial bladder cancer 66 brivanib 66 Quinamed 66 investigational immunotherapy 66 prostate cancer HRPC 66 sorafenib Nexavar ® 66 cyclophosphamide chemotherapy 66 CD# expressing 66 potent antiproliferative 66 NASH Huntington 66 gemcitabine carboplatin 66 AVAPRO 66 Nexavar ® 66 metaglidasen 66 psoriasis inflammatory bowel 66 refractory acute myeloid 66 progressive metastatic prostate 66 dependent kinase inhibitor 66 CDK cyclin dependent 66 2 methoxyestradiol 66 lymphoid malignancies 66 MKC# MKC# PP 66 pregabalin Lyrica 66 GTC recombinant human 66 Serostim ® 66 plus COPEGUS 66 immunotherapeutic agent 66 leukemia AML 66 Panzem R NCD 66 Kinase Inhibitor 66 Prolongs Survival 66 phase III isavuconazole 66 FEMALES SHOULD BE ADVISED 66 advanced hepatocellular carcinoma 66 acadesine 66 rheumatoid arthritis RA psoriatic 66 Sodium oxybate 66 Completes Patient Enrollment 66 radiation chemoradiation 66 Navelbine ® 66 non thiazolidinedione TZD 66 Epothilone D 65 By JENNIFER LEARN 65 tiuxetan 65 agonistic human 65 label Lipofen R 65 OncoVex 65 esophageal candidiasis 65 colorectal bladder 65 sunitinib Sutent 65 ZACTIMA 65 fallopian tube cancers 65 Lenalidomide 65 Bezielle 65 ENL recurrence 65 5 HT2A inverse 65 androgen receptor antagonist 65 Cannabinor 65 forodesine 65 ACTEMRA TM 65 erythematosus 65 Novel Oral 65 decompensated liver disease 65 Chronic Lymphocytic Leukemia 65 serologically active systemic lupus 65 systemic juvenile idiopathic 65 radiation sensitizer 65 PKC# 65 substantially excreted 65 Aplidin 65 Previously Untreated 65 diagnostic molecular imaging 65 paclitaxel Taxol ® 65 Selzentry Celsentri 65 R roscovitine CDK cyclin 65 agent VDA 65 Myelodysplastic Syndrome MDS 65 Paraplatin ® 65 Methylnaltrexone 65 Phase 2b Clinical Trial 65 Evoltra ® 65 HYVISC ® treatment 65 chimeric monoclonal antibody 65 HGS ETR2 65 delta gamma agonist 65 huC# DM4 65 hepatitis C HCV 65 Initiate Phase 65 taxane chemotherapy administered 65 TELINTRA R 65 Elagolix 65 hormone LHRH antagonist 65 BENLYSTA TM 65 vaccines oncolytic virus 65 Taxanes 65 rALLy clinical trial 65 Mycophenolate Mofetil 65 leukemia lymphoma multiple myeloma 65 erlotinib Tarceva R 65 Lambert Eaton Myasthenic 65 Pathway Inhibitor 65 Pegloticase 65 OMP #R# 65 metastatic androgen independent 65 intravesical instillation 65 gastro intestinal inflammation 65 iobenguane 65 prokinetic agent 65 memantine HCl 65 Randomized Phase II 65 recurrent metastatic 65 Initiates Phase III 65 R bendamustine hydrochloride 65 galiximab 65 PROVENGE ® 65 Chronic Myelogenous Leukemia CML 65 EGFR mutation positive 65 ocular formulation 65 KRN# 65 lintuzumab SGN 65 polyneuropathy HIV DSP 65 evaluating T DM1 65 RANK Ligand inhibitor 65 Anthracycline 65 pegylated interferon alfa 2a 65 Maribavir 65 Sapacitabine 65 Trastuzumab DM1 65 VICTOR E3 65 Kuvan sapropterin dihydrochloride 65 HGS# 65 Traficet EN 65 INVANZ 65 psoriasis rheumatoid arthritis 65 smoldering multiple myeloma 65 bortezomib Velcade R 65 Humanized Anti 65 TRIOLEX HE# APOPTONE HE# 65 Epidermal Growth Factor Receptor 65 selective modulator 65 investigational humanized monoclonal antibody 65 refractory gout 65 refractory colorectal cancer 65 targets EpCAM expressing 65 pharmacogenomic translational research 65 FDA APPROVES 65 ALVESCO ® 65 sorafenib Nexavar R 65 ALN HPN 65 oral nucleoside analogue 65 refractory indolent non 65 Potassium Chloride Sodium Ascorbate 65 infectious diseases autoimmune 65 either acutely decompensated 65 basal cell carcinoma BCC 65 acid phosphatase PAP 65 following fluoropyrimidine oxaliplatin 65 Gel repository corticotropin injection 65 Renal Cell Carcinoma 65 hepatitis B HBV 65 D aspartate NMDA receptor 65 Romiplostim 65 echinocandin 65 including eniluracil ADH 65 RAS MAPK pathway 65 carcinoma mCRC 65 Cloretazine ® 65 Serostim R 65 novel topoisomerase 65 delay bone metastases 65 CYP#A# CYP#D# 65 relapsing multiple sclerosis 65 Pooled Analysis 65 alkylating 65 factor TNF 65 differentiated thyroid 65 CML CP 65 targeting miR 65 systemic RNAi therapeutic 65 Mitoxantrone 65 metastatic bladder 65 adjuvant GIST 65 gastrointestinal stromal tumors GISTs 65 IMA# 65 Hormone Refractory Prostate Cancer 65 antimitotic 65 leukemia APL 65 Meets Primary Endpoint 65 refractory acute promyelocytic 65 HCV NS5B polymerase 65 LymphoStat B TM 65 Kristalose ® lactulose 65 epithelial tumors 65 alpha folate receptor 65 protein tyrosine phosphatase 1B 65 Copegus ® 65 Viread tenofovir disoproxil fumarate 65 imatinib Gleevec 65 docetaxel Injection Concentrate 65 alpha interferons 65 ospemifene 65 NYSE PFE Exelon Rivastigmine 65 abacavir lamivudine 65 highly purified pasteurized 65 IAP inhibitor 65 EGFR HER2 65 including cyclosporine methotrexate 65 VELCADE melphalan 65 cardiometabolic diseases Glucophage 65 R bisoprolol Euthyrox 65 Telik logo TELINTRA 65 Begins Dosing 65 non metastatic osteosarcoma 65 metastatic malignant melanoma 65 MEK Inhibitor 65 multicenter Phase III 65 Systemic Sclerosis 65 Carcinoid tumors 65 Hepatocellular Carcinoma HCC 65 tigecycline 65 YONDELIS R 65 Fovea Pharmaceuticals subsidiary 65 small molecule glucokinase 65 triciribine phosphate monohydrate 65 hypertrichosis occurred 65 Vincristine 65 thetreatment 65 completely resected 65 PEGINTRON TM 65 fluoropyrimidine 65 SinuNase TM 65 sapropterin dihydrochloride 65 Advanced Melanoma 65 EGFR tyrosine kinase inhibitor 65 Gemzar gemcitabine 65 pyrimidine nucleoside analog 65 docetaxel Taxotere 65 PrevOnco 65 EOquin TM phase 65 demethylation agents 65 huN# DM1 65 mitoxantrone plus 65 oncologic diseases 65 cetuximab Erbitux ® 65 Panzem R 65 somatostatin analog 65 mGluR5 negative 65 treat atopic dermatitis 65 lenalidomide Revlimid ® 65 dihydrochloride Tablets 65 please visit www.abraxane.com 65 histone deacetylase inhibitor 65 tyrosine kinase inhibitor TKI 64 NU# direct 64 ovarian pancreatic 64 peginterferon alfa 2a Pegasys 64 receiving chemoradiation therapy 64 broad spectrum cephalosporin 64 ADP receptor antagonist 64 oral picoplatin 64 tumor angiogenesis inhibitors 64 mRCC 64 Camptosar ® 64 reslizumab 64 post herpetic 64 invasive candidiasis 64 minimally symptomatic metastatic castrate 64 gemcitabine Gemzar ® 64 NS5B polymerase 64 HERCEPTIN 64 Presents Positive 64 hematological malignancy 64 gastrointestinal stromal tumor 64 plus fludarabine 64 Lymphocytic 64 hypervascular tumors 64 Solazed ™ 64 naïve HCV 64 Nilotinib 64 acute promyelocytic leukemia APL 64 refractory Hodgkin lymphoma 64 Factor Receptor 64 oral antiviral 64 R ferumoxytol Injection 64 M# rationally 64 autologous cellular immunotherapy 64 Torisel temsirolimus 64 TNFerade ™ 64 TNFerade TM 64 fluoroquinolone class 64 relapsed Acute Myeloid 64 interstitial cystitis IC 64 IL# PE#QQR 64 Zalypsis 64 oral JAK#/JAK# inhibitor 64 Carbamazepine 64 platform HDL Mimetic 64 selective angiogenic kinase inhibitor 64 leukemia multiple myeloma 64 BENLYSTA belimumab 64 Triapine 64 Pirfenidone 64 Namenda Memantine HCl 64 Genasense ® 64 personalized cellular immunotherapy 64 Pertuzumab 64 polycythemia vera essential thrombocythemia 64 Oracea TM 64 Pralatrexate 64 aflibercept VEGF Trap 64 JAK2 Inhibitor 64 Saizen R 64 ara C 64 transthyretin TTR mediated amyloidosis 64 worsening thrombocytopenia 64 CYT# vascular disrupting 64 fosbretabulin 64 Study Evaluating 64 novel histone deacetylase 64 prescription laxative 64 gets USFDA nod 64 Clevudine 64 opioid induced constipation OIC 64 selective orally bioavailable 64 Liprotamase 64 BENLYSTA ® 64 EGFR TKI 64 Castration Resistant Prostate Cancer 64 Files IND 64 Xeloda capecitabine 64 ™ pralatrexate injection 64 Clofarabine 64 Altera Nebulizer System 64 carcinoma HCC 64 Severe Sepsis 64 topical non steroidal 64 topoisomerase II inhibitor 64 oropharyngeal candidiasis 64 Cytogen marketed 64 Nexavar tablets 64 Onalta TM 64 diarrhea fatigue asthenia 64 oral anti arrhythmic 64 Ozarelix 64 selective antagonist 64 non porcine pancreatic 64 hematological diseases 64 buccal tablets 64 assessing T DM1 64 clinical trials Archexin 64 pharmacologically active isomer 64 lung malignant melanoma 64 metastatic hormone refractory 64 minimally symptomatic 64 FUSILEV ® 64 Alferon LDO 64 class anticancer quinolone 64 treat benign prostatic 64 refractory Ph + 64 Onalta ™ 64 Hedgehog Pathway Inhibitor 64 Firdapse TM amifampridine phosphate 64 recurrent malignant glioma 64 LEUKINE 64 Alemtuzumab 64 infliximab monotherapy 64 peritumoral brain edema 64 luteinizing hormone releasing 64 METOZOLV TM ODT metoclopramide 64 undergoing hematopoietic stem 64 EGFr expressing mCRC 64 tubulin inhibitor 64 ® decitabine 64 mTOR inhibitor 64 CEQ# 64 irinotecan chemotherapy 64 Pivotal Phase III 64 Belimumab 64 Carfilzomib 64 bone marrow reticulin deposition 64 Previously Treated 64 antisense inhibitors 64 Ophena TM 64 Randomized Double blind 64 Atripla combines 64 relapsed refractory aggressive 64 Orally administered 64 NS5b 64 Cancer Incidence Mortality 64 antimetabolite 64 Akt inhibitor 64 unresectable 64 palonosetron hydrochloride Injection Dacogen 64 KRAS mutant 64 panitumumab Vectibix 64 gemcitabine Gemzar 64 post herpetic neuralgia PHN 64 ongoing Phase 1b 64 Squamous 64 undergoing elective percutaneous 64 nanofiltered plasma derived 64 irreversible inhibitor 64 vWD 64 BRIM2 64 XL# anticancer compounds 64 targeting CD# 64 investigational monoclonal antibody 64 commercializes oncology 64 castration resistant hormone refractory 64 evaluating Actimmune 64 ACAPODENE TM 64 MYLOTARG 64 BRAF inhibitor 64 SUTENT ® 64 Copegus R 64 CIMZIA TM certolizumab pegol 64 HDAC Inhibitor 64 estrogen receptor beta agonist 64 non metastatic resectable 64 Gleevec imatinib mesylate 64 EPIVIR 64 TM pralatrexate injection 64 intranasal formulation 64 IMiDs 64 5 HT3 antagonist 64 Pemetrexed 64 overactive bladder VANTAS R 64 PORxin TM platforms 64 advanced metastatic prostate 64 prostate cancer mCRPC 64 TNF alpha selectively neutralizing 64 evaluating satraplatin plus 64 Nitazoxanide 64 developing Zerenex ferric 64 metastatic colorectal carcinoma 64 benign prostatic hypertrophy BPH 64 TAXUS Element Paclitaxel Eluting 64 allosteric modulator NAM 64 nucleoside naive 64 cyclobenzaprine hydrochloride extended 64 approved incretin mimetic 64 Systemic lupus erythematosus SLE 64 5q MDS 64 Relapsed Refractory Multiple Myeloma 64 unresectable stage 64 Tyrosine Kinase Inhibitor 64 compound perifosine 64 Veronate R 64 Fluorouracil 64 monoclonal antibody IgG1 Mab 64 influenza BCX# purine nucleoside 64 Intravenous Human 64 Imatinib mesylate 64 PROCTOCORT R Suppository Hydrocortisone 64 hyaluronidase enzyme 64 CYP#A# isoenzyme 64 lung ovarian 64 miconazole Lauriad ® 64 etanercept Enbrel 64 androgen independent 64 Recurrent Glioblastoma 64 Bevacizumab Avastin 64 CD3 monoclonal antibody 64 Leukemias 64 gastrointestinal mucositis 64 Solzira ™ 64 neutropenia dehydration dyspnea 64 dacarbazine DTIC 64 refractory multiple myeloma 64 Talactoferrin 64 oral dihydropyrimidine dehydrogenase DPD 64 Luveris R Ovidrel R 64 AEG# 64 castrate resistant 64 candidate deforolimus 64 anionic backbone 64 Xanafide 64 catheter occlusion 64 Completes Enrollment 64 Curis collaborator Genentech 64 CTA# Injection 64 Eculizumab 64 e antigen HBeAg 64 aripiprazole Abilify 64 CCR9 antagonist 64 Obatoclax 64 PANVAC VF 64 antiproliferative effects 64 sulfonylhydrazine class 64 highly selective endothelin 64 generation radiolabeled antibody 64 Lenocta TM 64 Chronic Hepatitis C 64 purified inactivated vaccine 64 Rituxan rituximab 64 Presents Preclinical Data 64 cisplatin resistant 64 Plecanatide 64 dirucotide MBP# 64 headache nasopharyngitis 64 Temsirolimus 64 biodefense pathogens 64 Hematological Malignancies 64 Fludarabine 64 Emergent marketed 64 Selective Internal 64 Denufosol 64 Aztreonam lysine 64 AVONEX ® 64 HCD# [002] 64 lymphomas leukemias 64 refractory unresponsive 64 MOVIPREP R 64 Randomized Double Blind 64 oral proteasome inhibitor 63 topical antifungal 63 DNAwithPap TM Test 63 resistant ovarian cancer 63 Diabetic Macular Edema DME 63 ACTIQ ® 63 Gefitinib 63 Demonstrates Potential 63 cytidine nucleoside analog 63 Reminyl galantamine 63 ixabepilone 63 Taxotere docetaxel 63 TTF Therapy 63 Sphingomab TM 63 Multiple Myeloma MM 63 Temodar ® 63 Radiation Therapy SIRT 63 Certolizumab pegol 63 non squamous NSCLC 63 Solution XOPENEX HFA 63 Vitrasert ® 63 NEBIDO R 63 interferon alfa 2b 63 eosinophilic asthma 63 capecitabine Xeloda 63 relapsed ovarian cancer 63 MDS MPD 63 pelvic malignancies 63 Cotara ® 63 cromolyn sodium 63 pain palliation 63 Chronic HCV 63 epithelial ovarian 63 PROSTASCINT R 63 Zolinza 63 IMPDH inhibitor 63 generation Hsp# inhibitor 63 FOLFOX6 63 hyperphenylalaninemia HPA due 63 metastatic carcinoid 63 Ixempra 63 telomerase inhibitor drug 63 BCG refractory 63 Apaziquone 63 Investigational Oral 63 Monoclonal antibody 63 pyrexia mucositis sepsis febrile 63 oral transmucosal fentanyl citrate 63 hepatocellular carcinoma HCC 63 refractory peripheral T 63 chronic ITP patients 63 UCB www.ucb group.com 63 Initiate Phase III 63 pertuzumab 63 Xyfid TM 63 Prednisone Against Refractory 63 Auxilium transmucosal film 63 Granulocyte Colony Stimulating Factor 63 melphalan prednisone 63 neuroendocrine cancers 63 rheumatoid arthritis systemic lupus 63 ovarian endometrial 63 Viagra Soft Cialis Soft 63 Interferon alpha 2b 63 Heterozygous Familial Hypercholesterolemia 63 metastatic HER2 positive 63 MGd 63 metastatic RCC 63 non resectable metastatic 63 Chronic Lymphocytic Leukemia CLL 63 VANTAS ® 63 HSP# inhibitor 63 Neoadjuvant 63 Cytotoxic 63 Folfox 63 polycythemia vera PV 63 OMP #M# 63 trastuzumab Herceptin ® 63 oral chemotherapeutic agent 63 exocrine pancreatic insufficiency EPI 63 systemic lupus erythematosus rheumatoid 63 Application MAA 63 develop HBV reactivation 63 transcriptase inhibitor NNRTI 63 oral ridaforolimus 63 Glufosfamide 63 Pegasys ® 63 Newly Diagnosed Multiple Myeloma 63 TNF Blockers 63 Daptomycin 63 Metastatic Prostate Cancer 63 Frozen Shoulder syndrome Adhesive 63 Epivir R 63 Tanespimycin 63 deCODE ProstateCancer TM 63 psoriatic arthritis PsA 63 Glioblastoma Multiforme 63 combining voreloxin 63 known sulfonamide allergy 63 receiving VELCADE 63 semi synthetic lipoglycopeptide